Supply of API 20 E Strips for Microbiological Testing

The contract involves the supply of API 20 E Strips, which are essential tools used for the identification of Enterobacteriaceae and other Gram-negative bacteria, specifically for laboratory testing conducted by the FDA. These strips play a critical role in microbiological analyses, supporting accurate and efficient bacterial identification in compliance with regulatory standards. The contract falls under the NAICS code 325412, indicating it is related to pharmaceutical preparation manufacturing. Issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, the subcontract solicitation was posted on May 7, 2026, with a response deadline of May 15, 2026. While specific details such as solicitation number, point of contact, and exact place of performance remain unspecified, the procurement focuses on meeting the FDA’s operational needs for reliable microbiological testing supplies. This contract underscores the agency’s commitment to maintaining high-quality standards in health and safety through dependable laboratory materials.